Management of Proctitis Following Colostomy
For patients with proctitis following colostomy, treatment with probiotics such as VSL#3 is recommended, particularly if antibiotic treatment has failed. 1
Understanding Proctitis in Colostomy Patients
Proctitis (inflammation of the rectum) can occur in patients with a colostomy due to several mechanisms:
- Diversion proctitis: When the fecal stream is diverted through a colostomy, the rectum becomes defunctionalized, leading to inflammation due to lack of normal bacterial colonization and short-chain fatty acid production
- Pre-existing inflammatory conditions: In patients with underlying inflammatory bowel disease (IBD) who required colostomy
- Radiation-induced proctitis: In patients who had colostomy following pelvic radiation
Diagnostic Approach
- Symptoms: Rectal discharge, bleeding, pain, tenesmus, and discomfort
- Endoscopic evaluation: Pouchoscopy/proctoscopy to assess the degree of inflammation, ulceration, and to rule out other causes
- Biopsies: To confirm inflammation and exclude other pathologies like Crohn's disease or malignancy
Treatment Algorithm
First-Line Treatments:
Topical treatments:
- Mesalamine suppositories or enemas
- Corticosteroid suppositories or enemas for acute inflammation
- Sucralfate enemas for ulcerative proctitis
Probiotics:
- VSL#3 is strongly recommended for treatment of proctitis, particularly in patients who have failed antibiotic therapy 1
- The probiotic mixture VSL#3 has shown effectiveness in preventing and treating inflammation in the defunctionalized rectum
Nutritional support:
- Ensure adequate albumin levels, as higher albumin levels significantly improve treatment effectiveness in ulcerative proctitis 2
For Refractory Cases:
Antibiotics:
- Metronidazole or ciprofloxacin for suspected bacterial overgrowth
- Combination therapy may be considered in severe cases
Fecal diversion devices:
- Rectal diversion devices can be used to protect the inflamed rectal mucosa from further irritation 1
Negative pressure wound therapy (NPWT):
- Can be considered for wound management after complete removal of necrotic tissue in severe cases 1
For Severe or Persistent Proctitis:
Formalin application:
- For hemorrhagic radiation proctitis that doesn't respond to other treatments 3
Surgical options:
- Proctectomy should be considered for refractory cases despite optimal medical therapy 1
- This is particularly important in cases with chronic active symptoms or complications
Special Considerations
For Radiation-Induced Proctitis:
- Diverting colostomy itself has shown an overall effective rate of 49.2% in treating ulcerative chronic radiation proctitis
- Highest effectiveness (88.2%) is achieved when colostomy is maintained for 12-24 months 2
- Nearly all patients (100%) with rectal bleeding and 91.4% with anal pain experience significant relief after colostomy
For Inflammatory Bowel Disease Patients:
- Active inflammation in the rectal stump after subtotal colectomy occurs in approximately 80% of ulcerative colitis patients 4
- This inflammation is a predictor for the development of pouchitis if ileal pouch-anal anastomosis is performed later
- Persistent proctitis may require proctectomy in patients with refractory disease 1
Monitoring and Follow-up
- Regular endoscopic assessment of the rectal stump
- Monitor for complications such as strictures, fistulas, or malignancy
- Assess nutritional status, particularly albumin levels, as this affects treatment outcomes 2
Pitfalls to Avoid
- Delayed recognition: Proctitis symptoms may be overlooked in colostomy patients since the rectum is defunctionalized
- Inadequate treatment duration: Effective treatment of ulcerative proctitis often requires 12-24 months of therapy 2
- Overlooking nutritional status: Low albumin levels negatively impact healing and treatment effectiveness 2
- Premature colostomy reversal: Reversing colostomy before complete healing of proctitis can lead to symptom recurrence
By following this structured approach to managing proctitis in colostomy patients, clinicians can effectively address this challenging condition and improve patient outcomes.